Real-World Dose Adjustment and Switching of Interleukin-17/23 Inhibitors for Thai Psoriasis
Interleukin (IL)-17 and IL-23 inhibitors have transformed psoriasis care, delivering high clearance rates and quality-of-life gains. Nevertheless, inadequate response or adverse events can lead to treatment discontinuation or biologic switching. Dose modifications are also commonly implemented in ro...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2026-01-01
|
| シリーズ: | Dermatology Research and Practice |
| オンライン･アクセス: | http://dx.doi.org/10.1155/drp/7998583 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|